Skye Bioscience Statistics

Total Valuation

SKYE has a market cap or net worth of $165.32 million. The enterprise value is $77.73 million.

Market Cap	165.32M
Enterprise Value	77.73M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SKYE has 28.07 million shares outstanding. The number of shares has increased by 643.18% in one year.

Shares Outstanding	28.07M
Shares Change (YoY)	+643.18%
Shares Change (QoQ)	+299.65%
Owned by Insiders (%)	2.19%
Owned by Institutions (%)	58.28%
Float	11.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.10
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.99, with a Debt / Equity ratio of 0.06.

Current Ratio	5.99
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.30

Financial Efficiency

Return on equity (ROE) is -212.30% and return on invested capital (ROIC) is -45.14%.

Return on Equity (ROE)	-212.30%
Return on Assets (ROA)	-120.40%
Return on Capital (ROIC)	-45.14%
Revenue Per Employee	n/a
Profits Per Employee	-$3.41M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SKYE has paid $5,600 in taxes.

Income Tax	5,600
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24,039.34% in the last 52 weeks. The beta is 1.77, so SKYE's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	+24,039.34%
50-Day Moving Average	9.60
200-Day Moving Average	7.29
Relative Strength Index (RSI)	34.35
Average Volume (20 Days)	386,339

Short Selling Information

The latest short interest is 670,259, so 2.39% of the outstanding shares have been sold short.

Short Interest	670,259
Short Previous Month	386,566
Short % of Shares Out	2.39%
Short % of Float	5.74%
Short Ratio (days to cover)	1.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.79M
Pretax Income	-37.49M
Net Income	-37.50M
EBITDA	-36.05M
EBIT	-36.17M
Earnings Per Share (EPS)	-$2.34

Full Income Statement

Balance Sheet

The company has $92.42 million in cash and $4.84 million in debt, giving a net cash position of $87.59 million or $3.12 per share.

Cash & Cash Equivalents	92.42M
Total Debt	4.84M
Net Cash	87.59M
Net Cash Per Share	$3.12
Equity (Book Value)	78.88M
Book Value Per Share	2.81
Working Capital	78.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.60 million and capital expenditures -$13,871, giving a free cash flow of -$14.61 million.

Operating Cash Flow	-14.60M
Capital Expenditures	-13,871
Free Cash Flow	-14.61M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SKYE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-643.18%
Shareholder Yield	-643.18%
Earnings Yield	-22.68%
FCF Yield	-8.84%

Analyst Forecast

The average price target for SKYE is $19.25, which is 226.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.25
Price Target Difference	226.83%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.01%

Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:250.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	1:250

Scores

Altman Z-Score	n/a
Piotroski F-Score	2